Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Sep 11 - Sep 16
MOTS-c activates AMPK to improve metabolic function, fat oxidation, and mitochondrial biogenesis
Research Use Notice
Relevant Research Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and meta-analysis of randomised controlled trials Retatrutide for the treatment of obesity, obstructive sleep apnea, and knee osteoarthritis: rationale and design of the TRIUMPH registrational clinical trials Retatrutidea game changer in obesity pharmacotherapy Unleashing the power of retatrutide: a possible triumph over obesity Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomised phase 2a trial Retatrutide in type 2 diabetes mellitus and obesity: an overview
Published work documents protective effects in models of stress-induced gastric ulceration, alcohol-induced gastric injury, NSAID-induced enteropathy, ulcerative colitis, and intestinal anastomosis healing
While their experiences may be genuine, personal anecdotes are not the same as scientific proof
General dose: 4 ml per 2 litres of drinking water
